Effect of genetic polymorphism of ALOX15 on aspirin-exacerbated respiratory disease

International Archives of Allergy and Immunology

Volumn 159, Issue 2, 2012, Pages 157-161

  Song, Young Sin ^a   Yang, Eun Mi ^a   Kim, Seung Hyun ^a   Jin, Hyun Jung ^a   Park, Hae Sim ^a  

^a Ajou University School of Medicine   (South Korea)

Author keywords

Arachidonate 15 lipoxygenase; Aspirin exacerbated respiratory disease; Eosinophil; Polymorphism

Indexed keywords

ACETYLSALICYLIC ACID; ARACHIDONATE 15 LIPOXYGENASE;

ADULT; ARTICLE; ASPIRIN EXACERBATED RESPIRATORY DISEASE; ASTHMA; CELL INFILTRATION; CONTROLLED STUDY; ENZYME ASSAY; EOSINOPHIL COUNT; FEMALE; GENE CONSTRUCT; GENE FREQUENCY; GENE FUNCTION; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GENOTYPE; HAPLOTYPE; HETEROZYGOTE; HUMAN; HUMAN TISSUE; KOREA; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROMOTER REGION; STATISTICAL SIGNIFICANCE;

ADULT; ARACHIDONATE 15-LIPOXYGENASE; ASIAN CONTINENTAL ANCESTRY GROUP; ASPIRIN; ASTHMA; ASTHMA, ASPIRIN-INDUCED; BASE SEQUENCE; CASE-CONTROL STUDIES; DNA PRIMERS; EOSINOPHILS; FEMALE; GENE FREQUENCY; HAPLOTYPES; HUMANS; LEUKOCYTE COUNT; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS, GENETIC; REPUBLIC OF KOREA; RESPIRATORY HYPERSENSITIVITY; YOUNG ADULT;

EID: 84861633534     PISSN: 10182438     EISSN: 14230097     Source Type: Journal    
DOI: 10.1159/000335681     Document Type: Article

References (29)

1. RU, Stevenson DD: Aspirin-exacerbated respiratory disease: evaluation and management. Allergy Asthma Immunol Res 2011; 3: 3-10.
2. Chang J, Simon RA, Stevenson DD: Aspirinexacerbated respiratory disease: is it in our DNA? Ann Allergy Asthma Immunol 2011; 106: 263-264.
3. Berges-Gimeno MP, Simon RA, Stevenson DD: The natural history and clinical characteristics of aspirin-exacerbated respiratory disease. Ann Allergy Asthma Immunol 2002; 89: 474-478.
4. Hamad AM, Sutcliffe AM, Knox AJ: Aspirininduced asthma: clinical aspects, pathogenesis and management. Drugs 2004; 64: 2417-2432.
5. Nasser SM, Pfister R, Christie PE, Sousa AR, Barker J, Schmitz-Schumann M, Lee TH: Inflammatory cell populations in bronchial biopsies from aspirin-sensitive asthmatic subjects. Am J Respir Crit Care Med 1996; 153: 90-96.
6. Palikhe NS, Kim SH, Cho BY, Choi GS, Kim JH, Ye YM, Park HS: IL-13 gene polymorphisms are associated with rhinosinusitis and eosinophilic inflammation in aspirin intolerant asthma. Allergy Asthma Immunol Res 2010; 2: 134-140.
7. Palikhe NS, Kim SH, Cho BY, Ye YM, Choi GS, Park HS: Genetic variability in CRTH2 polymorphism increases eotaxin-2 levels in patients with aspirin exacerbated respiratory disease. Allergy 2010; 65: 338-346.
8. Hamilos DL, Leung DY, Wood R, Bean DK, Song YL, Schotman E, Hamid Q: Eosinophil infiltration in nonallergic chronic hyperplastic sinusitis with nasal polyposis (CHS/ NP) is associated with endothelial VCAM-1 upregulation and expression of TNF-alpha. Am J Respir Cell Mol Biol 1996; 15: 443-450.
9. Mascia K, Borish L, Patrie J, Hunt J, Phillips CD, Steinke JW: Chronic hyperplastic eosinophilic sinusitis as a predictor of aspirin-exacerbated respiratory disease. Ann Allergy Asthma Immunol 2005; 94: 652-657.
10. Cowburn AS, Sladek K, Soja J, Adamek L, Nizankowska E, Szczeklik A, Lam BK, Penrose JF, Austen FK, Holgate ST, Sampson AP: Overexpression of leukotriene C 4 synthase in bronchial biopsies from patients with aspirin-intolerant asthma. J Clin Invest 1998; 101: 834-846.
11. Claesson HE: On the biosynthesis and biological role of eoxins and 15-lipoxygenase-1 in airway inflammation and Hodgkin lymphoma. Prostaglandins Other Lipid Mediat 2009; 89: 120-125.
12. Chanez P, Bonnans C, Chavis C, Vachier I: 15-lipoxygenase: a Janus enzyme? Am J Respir Cell Mol Biol 2002; 27: 655-658.
13. Bradding P, Redington AE, Djukanovic R, Conrad DJ, Holgate ST: 15-lipoxygenase immunoreactivity in normal and in asthmatic airways. Am J Respir Crit Care Med 1995; 151: 1201-1204.
14. Profita M, Sala A, Riccobono L, Paterno A, Mirabella A, Bonanno A, Guerrera D, Pace E, Bonsignore G, Bousquet J, Vignola AM: 15-lipoxygenase expression and 15(s)-hydroxyeicoisatetraenoic acid release and reincorporation in induced sputum of asthmatic subjects. J Allergy Clin Immunol 2000; 105: 711-716.
15. Liu C, Xu D, Liu L, Schain F, Brunnstrom A, Bjorkholm M, Claesson HE, Sjoberg J: 15-lipoxygenase-1 induces expression and release of chemokines in cultured human lung epithelial cells. Am J Physiol Lung Cell Mol Physiol 2009; 297:L196-L203.
16. Gulliksson M, Brunnstrom A, Johannesson M, Backman L, Nilsson G, Harvima I, Dahlen B, Kumlin M, Claesson HE: Expression of 15-lipoxygenase type-1 in human mast cells. Biochim Biophys Acta 2007; 1771: 1156-1165.
17. Vanderhoek JY: Role of the 15-lipoxygenase in the immune system. Ann NY Acad Sci 1988; 524: 240-251.
18. Claesson HE, Griffiths WJ, Brunnstrom A, Schain F, Andersson E, Feltenmark S, Johnson HA, Porwit A, Sjoberg J, Bjorkholm M: Hodgkin Reed-Sternberg cells express 15-lipoxygenase-1 and are putative producers of eoxins in vivo: novel insight into the inflammatory features of classical hodgkin lymphoma. FEBS J 2008; 275: 4222-4234.
19. Park HS: Early and late onset asthmatic responses following lysine-aspirin inhalation in aspirin-sensitive asthmatic patients. Clin Exp Allergy 1995; 25: 38-40.
20. Barrett JC, Fry B, Maller J, Daly MJ: Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 2005; 21: 263-265.
21. Lee HY, Kim SH, Ye YM, Choi GS, Park HS: Lack of association of ALOX12 and ALOX15 polymorphisms with aspirin-exacerbated respiratory disease in Korean patients. Ann Allergy Asthma Immunol 2009; 103: 84-86.
22. Moneret-Vautrin DA, Hsieh V, Wayoff M, Guyot JL, Mouton C, Maria Y: Nonallergic rhinitis with eosinophilia syndrome a precursor of the triad: nasal polyposis, intrinsic asthma, and intolerance to aspirin. Ann Allergy 1990; 64: 513-518.
23. Kowalski ML, Grzegorczyk J, Wojciechowska B, Poniatowska M: Intranasal challenge with aspirin induces cell influx and activation of eosinophils and mast cells in nasal secretions of ASA-sensitive patients. Clin Exp Allergy 1996; 26: 807-814.
24. Sladek K, Dworski R, Soja J, Sheller JR, Nizankowska E, Oates JA, Szczeklik A: Eicosanoids in bronchoalveolar lavage fluid of aspirin-intolerant patients with asthma after aspirin challenge. Am J Respir Crit Care Med 1994; 149: 940-946.
25. Chu HW, Balzar S, Westcott JY, Trudeau JB, Sun Y, Conrad DJ, Wenzel SE: Expression and activation of 15-lipoxygenase pathway in severe asthma: relationship to eosinophilic phenotype and collagen deposition. Clin Exp Allergy 2002; 32: 1558-1565.
26. Kowalski ML, Ptasinska A, Jedrzejczak M, Bienkiewicz B, Cieslak M, Grzegorczyk J, Pawliczak R, Dubuske L: Aspirin-triggered 15-HETE generation in peripheral blood leukocytes is a specific and sensitive Aspirin-Sensitive Patients Identification Test (ASPITest). Allergy 2005; 60: 1139-1145.
27. Feltenmark S, Gautam N, Brunnstrom A, Griffiths W, Backman L, Edenius C, Lindbom L, Bjorkholm M, Claesson HE: Eoxins are proinflammatory arachidonic acid metabolites produced via the 15-lipoxygenase-1 pathway in human eosinophils and mast cells. Proc Natl Acad Sci USA 2008; 105: 680-685.
28. Borrish L: Sinusitis and asthma: entering the realm of evidence-based medicine. J Allergy Clin Immunol 2002; 109: 606-608.
29. Stevenson DD, Zuraw BL: Pathogenesis of aspirin-exacerbated respiratory disease. Clin Rev Allergy Immunol 2003; 24: 169-188.